An FDA panel's July vote didn't make BPC-157 legal to compound. Here's what that means for the cost of peptide therapy.

Ellen Relkin, attorney and co-lead counsel in the New Jersey Ozempic lawsuits on NAION vision loss, shares exclusive insight and guidelines for anyone taking a GLP-1 medication.

The successes of the GLP-1 class for chronic weight management “introduced consumer overlay over a historically physician-driven therapeutic area,” Pothier explained, noting that despite the potency ...

The new interim final rule, issued by U.S. Customs and Border Protection (CBP), imposes an indefinite suspension of a ...

Big Pharma scoffed. But Daniel Drucker’s dogged pursuit of a secret buried in lizard genes propelled a mega medical ...

Federal prosecutors have charged two people in an alleged scheme to bring fake versions of the type 2 diabetes drug Ozempic ...

An investigation into Dutch media coverage of weight loss drugs that led to several outlets being fined for breaching ...

Ozempic was never mentioned. Neither was Mounjaro. But the promises of weight loss came thick and fast, text message by ...

TV ad for Lite N Easy starring comedian & social media star Christian Hull ...

Billy Gardell is opening up about his weight loss journey and how it actually started with being on Ozempic, though that didn ...

September 28, 2026) - Vimy Pharmaceuticals Inc. ("Vimy Pharma" or the "Company") and Harmony Acquisitions Corp. (TSXV: MONY.P) ("Harmony") are pleased to jointly announce the upsize and closing of the ...

Novo Nordisk has acquired Nanexa’s PharmaShell technology for 1.3 billion dollars (1.1 billion euros). The system enables long-acting injectable treatments for diabetes. Strateg ...